Authors

    Language

    English

    Publication Date

    5-1-2022

    Journal

    Reviews in Cardiovascular Medicine

    DOI

    10.31083/j.rcm2305157

    PMID

    39077617

    PMCID

    PMC11273972

    PubMedCentral® Posted Date

    4-27-2022

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    This review focuses on the strengths and limitations of conventional and high-sensitivity troponin in the evaluation of patients with suspected acute coronary syndromes. High-sensitivity troponin (hsTn) assays represent a significant innovation over prior generation troponin assays. Owing to superior analytical precision, hsTn permits more rapid "rule-in" and "rule-out" of myocardial infarction. Furthermore, hsTn assays, in properly implemented clinical pathways, permit a reduction in the portion of patients requiring extended observation and testing.

    Keywords

    troponin, high sensitivity troponin, chest pain, acute coronary syndrome, biomarkers

    Published Open-Access

    yes

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.